Indeed, FOXA1 has been hypothesized to be a mediator of hormonal response in breast and prostate cancer (Robinson and Carroll, 2012), and a hormonal regulatory complex involving FOXA1, GATA2 and AR has been shown to control gene expression in prostate cancer (Zhao et al., 2016). This evidence concerns the gene FOXA1 and Familial prostate cancer.